Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Shield

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Transplantation|January 1, 1993
A randomized clinical trial of induction therapy with OKT3 in kidney transplantationD J Norman, L Kahana, F P Stuart, et al.
Transplantation|December 27, 1995
Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRAC F Bryan, K A Baier, G Flora-Ginter, et al.
Transplantation Proceedings|February 1, 1996
Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization?A M Luger, C F Bryan, B J O'Brien, et al.
Clinical Transplantation|February 29, 2000
Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigensC F Bryan, C F Shield, G E Pierce, et al.
Transplantation|May 15, 2001
Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograftC F Bryan, A M Luger, J Martinez, et al.
Transplantation Proceedings|September 7, 2001
Effect of donor brain-death duration on graft outcomeN A Muruve, T S Helling, A M Luger, et al.
Transplantation|March 9, 2000
Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodiesR Kalluri, A Torre, C F Shield, et al.
Transplantation|December 27, 1996
HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serologyC F Bryan, K M Harrell, P W Nelson, et al.
JAMA|October 20, 1998
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) reportH M Lin, H M Kauffman, M A McBride, et al.
Transplantation|January 12, 1999
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatchingC F Bryan, K A Baier, P W Nelson, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Transplantation|January 1, 1993
A randomized clinical trial of induction therapy with OKT3 in kidney transplantationD J Norman, L Kahana, F P Stuart, et al.
Transplantation|December 27, 1995
Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRAC F Bryan, K A Baier, G Flora-Ginter, et al.
Transplantation Proceedings|February 1, 1996
Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization?A M Luger, C F Bryan, B J O'Brien, et al.
Clinical Transplantation|February 29, 2000
Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigensC F Bryan, C F Shield, G E Pierce, et al.
Transplantation|May 15, 2001
Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograftC F Bryan, A M Luger, J Martinez, et al.
Transplantation Proceedings|September 7, 2001
Effect of donor brain-death duration on graft outcomeN A Muruve, T S Helling, A M Luger, et al.
Transplantation|March 9, 2000
Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodiesR Kalluri, A Torre, C F Shield, et al.
Transplantation|December 27, 1996
HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serologyC F Bryan, K M Harrell, P W Nelson, et al.
JAMA|October 20, 1998
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) reportH M Lin, H M Kauffman, M A McBride, et al.
Transplantation|January 12, 1999
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatchingC F Bryan, K A Baier, P W Nelson, et al.
Pageof 9